Cite
HARVARD Citation
Peng, Z. et al. (2022). Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model‐based simulation analysis using 10‐year real‐world data and targeted literature review. Diabetes, obesity & metabolism. 24 (7), pp. 1328-1337. [Online].